What are the biological processes that stem cells go through? What are the industrial processes we need to manufacturing? What do we know about cancer stem cells? How do iPS cells fit into the picture vs. embryonic stem cells? In this episode we investigate how the science and research of stem cells is being translated into industrial cell processes to create FDA approvable, and commercializable products. Differentiation, proliferation, migration, retro-differentiation, trans-differentiation, transformation into cancer cells, the role of tumors‘ micro environments and epigenetics and all reviewed here by the field’s foremost experts.
Multiple Sclerosis Patients Update: After Second Stem Cell Treatment
It has been about 3 months since I last updated you on Preston Walker and Richard Humphries, the two Multiple Sclerosis Stem Cell Research pioneers who received their own Adult Stem Cells to improve their MS.
Since then, both have returned to Costa Rica to receive a second […]
Stem Cell Therapeutics Corp. or the wishes to announce the acceptance and publication of the paper entitled “The Beta-hCG + Erythropoietin in Acute Stroke (BETAS) Study” by the journal “Stroke”, on March 8, 2010.
This paper was authored by Dr. Steven C. Cramer, from the University of California, Irvine, Dr. David Brown at Hoag Memorial Hospital Presbyterian, New Port Beach, Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and colleagues.
Dr. Allen Davidoff, VP of Product Development, commented as follows:
“The Stroke journal, published by the American Heart Association, is the top journal in the field of stroke
Image via Wikipedia
A University of Bristol team extracted stem cells from the veins, then used them to stimulate new blood vessel growth in mice, Circulation reports.
The researchers say their findings could bring treatments to repair damaged heart muscle one step closer.
However, a stem cell expert warned that they remained some years away.
Stem cells are attractive to medical researchers because they have the ability to produce many different types of human cell, opening up the possibility of repair or renewal for tissues ravaged by disease or injury (…)
Image via Wikipedia
One of the most advanced research centers for the therapeutic applications of epithelial stem cells in the world, the ‘Stefano Ferrari’ regenerative medicine center at the University of Modena and Reggio Emilia, opened its doors with the ambitious goal of becoming the flagship research center in Italy. It was completely financed by the Modena Savings Bank, which invested 13 million euros for its completion and was inaugurated by Welfare Minister Maurizio Sacconi and Emilia-Romagna President Vasco Errani. It includes a new three floor, 30,000 square meter building (half of which is contamination controlled) at